Gene · 8828
Papers3,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapy-educated fibroblast states link treatment pressure to residual disease and acquired resistance in gastric cancer. | Front Immunol | 2026 | 42812889 | PubTator, text mining | PubMed |
| Exploring Genetic Clues in Kikuchi-Fujimoto Disease: A Three-Generation Study. | Pharmgenomics Pers Med | 2026 | 42724811 | PubTator, text mining | PubMed |
| Reversible Symmetry Switching, Giant Birefringence, and UV Second-Harmonic Generation in Hybrid Niobium Oxyfluorides. | Angew Chem Int Ed Engl | 2026 | 42690036 | PubTator, text mining | PubMed |
| Targeting Semaphorin-plexin Signaling in Glioblastoma: Implications for Tumor Invasion, Angiogenesis, and Treatment Resistance. | Curr Neurovasc Res | 2026 | 42634324 | PubTator, text mining | PubMed |
| Sensory neurons shape γδ T cell effector programs to control psoriasiform inflammation. | J Invest Dermatol | 2026 | 42551506 | PubTator, text mining | PubMed |
| Sensory neurons shape γδ T cell effector programs to control Psoriasiform Inflammation. | bioRxiv | 2026 | 42465452 | PubTator, text mining | PubMed |
| Single-cell mapping of extrachromosomal circular DNA architecture and evolution in cutaneous squamous cell carcinoma. | Cancer Lett | 2026 | 42457020 | PubTator, text mining | PubMed |
| [Retracted] miR-331-3p suppresses cell invasion and migration in colorectal carcinoma by directly targeting NRP2. | Oncol Lett | 2026 | 42433654 | PubTator, text mining | PubMed |
| New Therapies for Sarcoidosis: Molecular and Pathophysiological Basis. | Int J Mol Sci | 2026 | 42353055 | PubTator, text mining | PubMed |
| Integrative spatiotemporal transcriptomics identifies a liver metastasis-related initial cell population associated with the SEMA3A-NRP1 axis in pancreatic ductal adenocarcinoma. | J Transl Med | 2026 | 42304476 | PubTator, text mining | PubMed |
| Cytokine-induced NRP2 expression in rheumatoid arthritis fibroblast-like synoviocytes: comment on the article by Jin et al. | Arthritis Rheumatol | 2026 | 42261904 | PubTator, text mining | PubMed |
| Predictive epigenetic biomarkers of successful weight-loss intervention in pre-pubertal children with obesity. | Clin Epigenetics | 2026 | 42210364 | PubTator, text mining | PubMed |
| Neuropilins in Multiple Sclerosis: Dual Roles of NRP-1 in Neuroinflammation and Neuroprotection. | Neuromolecular Med | 2026 | 42207333 | PubTator, text mining | PubMed |
| Discovery and Cryo-EM-Guided Development of a Neuropilin-2-Binding Aptamer for Receptor Antagonism. | J Am Chem Soc | 2026 | 42166782 | PubTator, text mining | PubMed |
| C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics. | Cell Mol Neurobiol | 2026 | 42156560 | PubTator, text mining | PubMed |
| Cytomegalovirus pentamer dependent endocytic cellular infection utilizes redundant entry receptors in the guinea pig model. | bioRxiv | 2026 | 42146691 | PubTator, text mining | PubMed |
| Targeting CD3L1-NRP2 disarms myeloid-driven tumor immune evasion. | EMBO Mol Med | 2026 | 42141271 | PubTator, text mining | PubMed |
| Mechanisms by which chromobox homolog 4 regulates angiogenic mimicry and angiogenic activity in osteosarcoma. | J Pharmacol Exp Ther | 2026 | 42139798 | PubTator, text mining | PubMed |
| Reply. | Arthritis Rheumatol | 2026 | 42098590 | PubTator, text mining | PubMed |
| Cross-species single-cell transcriptomic analyses reveal evolutionary conservation and diversification of ovarian tissues. | J Anim Sci Biotechnol | 2026 | 41975518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8828/papers